Global Menin Inhibitor Drugs Insights Report 2023: Phase-II has the Highest Clinical Trials Phase, 10 Drugs in Clinical Trial, Clinical Significance, and Innovation Trends by US, Europe & Canada

DUBLIN, Dec. 18, 2023 /PRNewswire/ — The “Global Menin Inhibitor Drugs Clinical Trials & Future Opportunity Insight 2023” report has been added to ResearchAndMarkets.com’s offering. Menin represents a new generation of proteins that have found application as a therapeutic target in…